Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa The Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Experience (2011)
- Authors:
- Autor USP: BURDMANN, EMMANUEL DE ALMEIDA - FM
- Unidade: FM
- DOI: 10.1161/CIRCULATIONAHA.111.030411
- Subjects: DOENÇA CRÔNICA; REGRESSÃO LOGÍSTICA; ANEMIA; ERITROPOIETINA; DIABETES MELLITUS; NEFROPATIAS; ACIDENTE VASCULAR CEREBRAL
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Circulation
- ISSN: 0009-7322
- Volume/Número/Paginação/Ano: v. 124, n. 25, p. 2903-2908, 2011
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
SKALI, Hicham et al. Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa The Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Experience. Circulation, v. 124, n. 25, p. 2903-2908, 2011Tradução . . Disponível em: https://doi.org/10.1161/CIRCULATIONAHA.111.030411. Acesso em: 04 jun. 2024. -
APA
Skali, H., Parving, H. -H., Parfrey, P. S., Burdmann, E. A., Lewis, E. F., Ivanovich, P., et al. (2011). Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa The Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Experience. Circulation, 124( 25), 2903-2908. doi:10.1161/CIRCULATIONAHA.111.030411 -
NLM
Skali H, Parving H-H, Parfrey PS, Burdmann EA, Lewis EF, Ivanovich P, Keithi-Reddy SR, McGill JB, McMurray JJV, Singh AK, Solomon SD, Uno H, Pfeffer MA. Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa The Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Experience [Internet]. Circulation. 2011 ; 124( 25): 2903-2908.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.111.030411 -
Vancouver
Skali H, Parving H-H, Parfrey PS, Burdmann EA, Lewis EF, Ivanovich P, Keithi-Reddy SR, McGill JB, McMurray JJV, Singh AK, Solomon SD, Uno H, Pfeffer MA. Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa The Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Experience [Internet]. Circulation. 2011 ; 124( 25): 2903-2908.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.111.030411 - Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease
- Extracorporeal Treatment for Lithium Poisoning: systematic Review and Recommendations from the EXTRIP Workgroup
- Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial
- Peritoneal Dialysis in Acute Kidney Injury: Lessons Learned and Applied
- Acute kidney injury: global health alert
- Acute kidney injury: global health alert
- Predictive usefulness of unirary biomarkers for the identification of cyclosporine A induced nephrotoxicity in a rat model
- Cyclic Direct Radionuclide Cystography in the Diagnosis and Characterization of Vesicoureteral Reflux in Children and Adults
- Empatia em estudantes de Medicina: efeitos de um programa de gerenciamento do estresse
- Association of magnesium abnormalities at intensive care unit admission with kidney outcomes and mortality: a prospective cohort study
Informações sobre o DOI: 10.1161/CIRCULATIONAHA.111.030411 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
